Drug-associated disease: hematologic dysfunction.
Crit Care Clin
; 22(2): 347-55, viii, 2006 Apr.
Article
em En
| MEDLINE
| ID: mdl-16678004
ABSTRACT
Hematologic dysfunction, including thrombocytopenia, anemia, neutropenia, thromboses, and coagulopathy, occur commonly during critical illnesses. A major challenge is to identify drug-induced causes of hematologic dysfunction. Given the wide variety of drug-induced hematologic effects, clinicians always should consider any concomitant drugs in the differential diagnosis of acquired hematologic dysfunction. The most severe effects include drug-induced aplastic anemia, heparin-induced thrombocytopenia, and drug-induced thrombotic microangiopathy. Certain drugs are associated with multiple hematologic effects. For example, cisplatin can cause hemolytic uremia syndrome and erythropoietin deficiency, and quinine can precipitate immune-mediated thrombocytopenia, immune-mediated thrombocytopenia, and thrombotic microangiopathy.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Trombocitopenia
/
Heparina
/
Doenças Hematológicas
/
Anemia Aplástica
/
Anticoagulantes
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Crit Care Clin
Assunto da revista:
TERAPIA INTENSIVA
Ano de publicação:
2006
Tipo de documento:
Article
País de afiliação:
Estados Unidos